Skip to main content
. 2020 Feb 14;12(2):155. doi: 10.3390/pharmaceutics12020155

Figure 3.

Figure 3

Rebamipide release from REB-MPs and REB-NPs through 25 nm and 450 nm pore membranes. Drug release from REB-MPs and REB-NPs through (A) 25 nm and (B) 450 nm pore membranes. (C) Particle size and (D) number of rebamipide nanoparticles that passed through the 450 nm pore membrane 24 h after the application of REB-NPs. Data show the size distribution and number of nanoparticles in the reservoir chamber. n = 5–6. N.D., not detectable. *P < 0.05, vs. REB-MPs. The rebamipide solid was released as nanoparticles from REB-NPs.